Metabolism News and Research

Latest Metabolism News and Research

Researchers discover previously unknown function of key component in the immune system

The complement proteins that circulate in our blood are an important part of our immune system. They help identify bacteria, viruses and other harmful organisms, making it easier for our white blood cells to find and neutralize dangerous microbes.

5 Oct 2018

New approach could lead to precise treatments for traumatic brain injury

Traumatic head injury can have widespread effects in the brain, but now scientists can look in real time at how head injury affects thousands of individual cells and genes simultaneously in mice.

5 Oct 2018

Newly discovered compounds may explain whole grain health benefits

Scientists have discovered new compounds that may explain whole grain health benefits, reports a new study led by the University of Eastern Finland.

3 Oct 2018

Treating aged mice with natural product appears to have positive effects on health and lifespan

Previous research published earlier this year in Nature Medicine involving University of Minnesota Medical School faculty Paul D. Robbins and Laura J. Niedernhofer and Mayo Clinic investigators James L. Kirkland and Tamara Tchkonia, showed it was possible to reduce the burden of damaged cells, termed senescent cells, and extend lifespan and improve health, even when treatment was initiated late in life.

3 Oct 2018

Study highlights need for population-specific precision medicine programs in Latin America

Drug safety and effectiveness vary greatly among populations worldwide. Genetics is one of the factors that contribute to variability in drug response.

3 Oct 2018

Researchers decode anti-inflammatory mechanism of vitamin E and its metabolites

Vitamin E's positive effects often fail to manifest themselves as strongly as expected, but sometimes administering vitamin E actually has detrimental effects. An international team has now found a possible cause for this.

3 Oct 2018

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.

29 Sep 2018

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption - where there is consumption, there is cancer.

29 Sep 2018

Shared decision making needed to diagnose, treat, and manage patients with CAH

The Endocrine Society today issued a Clinical Practice Guideline that offers best practices for healthcare providers on how to promptly diagnose, treat, and manage patients with congenital adrenal hyperplasia, an inherited endocrine disorder, throughout their entire lives.

28 Sep 2018

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Approximately 1.25 million Americans are living with type 1 diabetes, with an additional 40,000 people newly diagnosed every year.

27 Sep 2018

Breastfeeding changes gene activity that regulates infant's response to stress

It has long been known that there are many physical and mental health benefits of breastfeeding for mothers and babies. But can these benefits be due to genetic changes induced by breastfeeding? New research suggests that connection.

27 Sep 2018

Moffitt researcher awarded World Molecular Imaging Society's highest honor

Robert Gillies, Ph.D., chair of the Department of Cancer Physiology and vice chair of Radiology Research at Moffitt Cancer Center, was awarded the World Molecular Imaging Society's highest honor.

27 Sep 2018

Researchers to explore sex differences in cardiovascular and renal physiology

A person's sex can be a defining factor in how well--or how poorly--they respond to disease, therapy and recovery. Experts at the forefront of sex-specific research will convene next week at the sixth APS conference on sex differences in cardiovascular and renal physiology.

26 Sep 2018

Cancer Research UK, Keystone Symposia collaborate for cancer-related research

Keystone Symposia and Cancer Research UK are pleased to announce their new collaboration consisting of a series of annual cancer-related scientific research conferences organized by Keystone Symposia in collaboration with Cancer Research UK.

26 Sep 2018

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Diabetes is an increasing global epidemic that is expected to grow by more than 50 percent in the next two decades, leaving more than half a billion patients worldwide exposed to potentially life-altering medical complications, including pain and numbness in the feet, lost limbs, life-threatening disorders of the heart, liver and kidneys -- and even blindness.

26 Sep 2018

Study reveals connection between hunger and mood

It seems "hangry" isn't just a made-up term. University of Guelph researchers have revealed that the sudden drop in glucose we experience when we are hungry can impact our mood.

25 Sep 2018

DFG establishes nine new Research Units

The Deutsche Forschungsgemeinschaft is establishing nine new Research Units, following a decision by the Senate and the Joint Committee in Bonn.

25 Sep 2018

Lancaster professor aims to understand how genes affect smoking cessation

The Canadian Institute of Health Research has awarded $929,475 to Professor Jo Knight of Lancaster Medical School, Lancaster Data Science Institute and the Department of Psychiatry at the University of Toronto.

25 Sep 2018

Gene therapy approach could help treat mitochondrial diseases

Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Metabolism News and Research

Latest Metabolism News and Research

Researchers discover previously unknown function of key component in the immune system

New approach could lead to precise treatments for traumatic brain injury

Newly discovered compounds may explain whole grain health benefits

Treating aged mice with natural product appears to have positive effects on health and lifespan

Study highlights need for population-specific precision medicine programs in Latin America

Researchers decode anti-inflammatory mechanism of vitamin E and its metabolites

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

Cancer undercuts ability of normal cells to consume glucose, finds study

Shared decision making needed to diagnose, treat, and manage patients with CAH

CIRM approves $1.6M grant to help bring human islet-like organoids to diabetic patients

Breastfeeding changes gene activity that regulates infant's response to stress

Moffitt researcher awarded World Molecular Imaging Society's highest honor

Researchers to explore sex differences in cardiovascular and renal physiology

Cancer Research UK, Keystone Symposia collaborate for cancer-related research

TGen-UNM consortium awarded NIH grant to discover new treatments for diabetic blindness

Study reveals connection between hunger and mood

DFG establishes nine new Research Units

Lancaster professor aims to understand how genes affect smoking cessation

Gene therapy approach could help treat mitochondrial diseases

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy